サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1468069

生体吸収性ステント市場レポート：生体材料、吸収率、用途、エンドユーザー、地域別、2024～2032年

Bioabsorbable Stents Market Report by Biomaterial, Absorption Rate, Application, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 137 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
生体吸収性ステント市場レポート：生体材料、吸収率、用途、エンドユーザー、地域別、2024～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

生体吸収性ステントの世界市場規模は2023年に4億940万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに7億6,420万米ドルに達し、2024～2032年の間に7％の成長率（CAGR）を示すと予測しています。

生体吸収性ステント（BRS）は、抗増殖薬または遺伝子でコーティングされており、時間の経過とともに溶解して血管の開存性を回復し、反動を維持しながらリモデリングを可能にします。低灌流で血流を維持しながら、分岐点での血流を調節し、血管網の領域への血液量を制限するのに役立ちます。また、心臓コンピュータ断層撮影法（CT）や磁気共鳴画像法（MRI）による病変の画像化も改善します。さらに、足場が残らず、血管の刺激や炎症が少なく、同じ部位への繰り返し治療が容易です。その結果、BRSは世界中の病院や心臓センターで幅広く応用されています。

生体吸収性ステントの市場動向：

不健康な食生活、運動不足、タバコやアルコールの過剰摂取による心血管疾患の有病率の増加は、市場を牽引する要因の一つです。さらに、酸素が豊富な血液を体内に運ぶために閉塞した動脈を開く経皮的冠動脈形成術（PCI）の利用が増加しています。これは医療産業の拡大とともに市場の成長に寄与しています。これに加えて、生体吸収性ステントの利点に関する大衆の意識の高まりが、業界の投資家に有利な成長機会を提供しています。加えて、術後痛の軽減、手術と術後合併症の減少、入院期間の短縮、回復時間の短縮による低侵襲手術への需要の高まりは、市場にプラスの影響を与えています。これとは別に、主要市場参入企業は研究開発（R&D）活動に積極的に投資しており、冠動脈疾患の治療にSLENDER Integrated Delivery System（IDS）固定ワイヤーやDIRECT RX生体吸収性急速交換型薬剤溶出ステント（DES）システムを導入しています。また、ポリマーをベースとしたステントの開発にも注力しており、市場の成長を後押しすると期待されています。

本レポートで扱う主要質問

  • 2023年の生体吸収性ステントの世界市場規模は？
  • 2024～2032年にかけての生体吸収性ステントの世界市場の予想成長率は？
  • 生体吸収性ステントの世界市場を牽引する主要因は？
  • COVID-19が生体吸収性ステントの世界市場に与えた影響は？
  • 生体材料別の生体吸収性ステントの世界市場の内訳は？
  • 吸収率別の生体吸収性ステントの世界市場の内訳は？
  • 用途別の生体吸収性ステントの世界市場の内訳は？
  • エンドユーザー別の生体吸収性ステントの世界市場の内訳は？
  • 生体吸収性ステントの世界市場における主要地域は？
  • 生体吸収性ステントの世界市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 生体吸収性ステントの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：生体材料別

  • ポリマー系生体吸収性ステント
  • 金属系生体吸収性ステント

第7章 市場内訳：吸収率別

  • 低速吸収ステント
  • 高速吸収ステント

第8章 市場内訳：用途別

  • 冠動脈疾患
  • 末梢動脈疾患

第9章 市場内訳：エンドユーザー別

  • 病院
  • 心臓センター

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Arterius Limited
    • B. Braun SE
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • Elixir Medical Corporation
    • Kyoto Medical Planning Co. Ltd.
    • Lepu Medical Technology（Beijing）Co. Ltd.
    • Meril Life Sciences Pvt. Ltd.
    • Reva Medical LLC
    • Terumo Corporation
図表

List of Figures

  • Figure 1: Global: Bioabsorbable Stents Market: Major Drivers and Challenges
  • Figure 2: Global: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Bioabsorbable Stents Market: Breakup by Biomaterial (in %), 2023
  • Figure 5: Global: Bioabsorbable Stents Market: Breakup by Absorption Rate (in %), 2023
  • Figure 6: Global: Bioabsorbable Stents Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Bioabsorbable Stents Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Bioabsorbable Stents Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Bioabsorbable Stents (Polymer-based Bioabsorbable Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Bioabsorbable Stents (Polymer-based Bioabsorbable Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Bioabsorbable Stents (Metal-based Bioabsorbable Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Bioabsorbable Stents (Metal-based Bioabsorbable Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Bioabsorbable Stents (Slow-Absorption Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Bioabsorbable Stents (Slow-Absorption Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Bioabsorbable Stents (Fast-Absorption Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Bioabsorbable Stents (Fast-Absorption Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Bioabsorbable Stents (Coronary Artery Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Bioabsorbable Stents (Coronary Artery Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Bioabsorbable Stents (Peripheral Artery Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Bioabsorbable Stents (Peripheral Artery Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Bioabsorbable Stents (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Bioabsorbable Stents (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Bioabsorbable Stents (Cardiac Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Bioabsorbable Stents (Cardiac Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: North America: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: North America: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: United States: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: United States: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Canada: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Canada: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Asia-Pacific: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Asia-Pacific: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: China: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: China: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Japan: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Japan: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: India: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: India: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: South Korea: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: South Korea: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Australia: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Australia: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Indonesia: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Indonesia: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Others: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Others: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Europe: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Europe: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Germany: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Germany: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: France: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: France: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: United Kingdom: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: United Kingdom: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Italy: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Italy: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Spain: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Spain: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Russia: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Russia: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Others: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Others: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Latin America: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Latin America: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Brazil: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Brazil: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Mexico: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Mexico: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Others: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Others: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Middle East and Africa: Bioabsorbable Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Middle East and Africa: Bioabsorbable Stents Market: Breakup by Country (in %), 2023
  • Figure 73: Middle East and Africa: Bioabsorbable Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Global: Bioabsorbable Stents Industry: SWOT Analysis
  • Figure 75: Global: Bioabsorbable Stents Industry: Value Chain Analysis
  • Figure 76: Global: Bioabsorbable Stents Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bioabsorbable Stents Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Bioabsorbable Stents Market Forecast: Breakup by Biomaterial (in Million US$), 2024-2032
  • Table 3: Global: Bioabsorbable Stents Market Forecast: Breakup by Absorption Rate (in Million US$), 2024-2032
  • Table 4: Global: Bioabsorbable Stents Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Bioabsorbable Stents Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Bioabsorbable Stents Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Bioabsorbable Stents Market: Competitive Structure
  • Table 8: Global: Bioabsorbable Stents Market: Key Players
目次
Product Code: SR112024A6082

The global bioabsorbable stents market size reached US$ 409.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 764.2 Million by 2032, exhibiting a growth rate (CAGR) of 7% during 2024-2032.

Bioabsorbable stents (BRS) are coated with an antiproliferative drug or gene that dissolves over time to restore vessel patency and permit remodeling while retaining recoil. It helps in regulating blood flow at branch points and limiting the amount of blood to areas of the vascular network while maintaining the flow at low perfusion. It also improves lesion imaging with cardiac computed tomography (CT) and magnetic resonance imaging (MRI). In addition, it leaves no residual scaffold, reduces vessel irritation and inflammation, and facilitates repeat treatments to the same site. As a result, BRS finds extensive applications in hospitals and cardiac centers across the globe.

Bioabsorbable Stents Market Trends:

The growing prevalence of cardiovascular diseases due to an unhealthy diet, physical inactivity, and excessive consumption of tobacco and alcohol represents one of the factors driving the market. Moreover, there is a rise in the utilization of percutaneous coronary intervention (PCI) procedures to open a blocked artery for carrying oxygen-rich blood through the body. This, along with the expanding healthcare industry, is contributing to the growth of the market. Besides this, the increasing awareness among the masses about the benefits of bioabsorbable stents is offering lucrative growth opportunities to industry investors. In addition, the growing demand for minimally invasive procedures due to less postoperative pain, fewer operative and postoperative complications, shortened hospital stay, and faster recovery times is positively influencing the market. Apart from this, key market players are extensively investing in research and development (R&D) activities to introduce SLENDER integrated delivery system (IDS) fixed-wire and DIRECT RX bioabsorbable rapid-exchange drug-eluting stent (DES) systems to treat coronary artery disease. They are also focusing on developing polymer-based stents, which is expected to bolster the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global bioabsorbable stents market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on biomaterial, absorption rate, application and end user.

Breakup by Biomaterial:

Polymer-based Bioabsorbable Stents

Metal-based Bioabsorbable Stents

Breakup by Absorption Rate:

Slow-Absorption Stents

Fast-Absorption Stents

Breakup by Application:

Coronary Artery Disease

Peripheral Artery Disease

Breakup by End User:

Hospitals

Cardiac Centers

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arterius Limited, B. Braun SE, Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Kyoto Medical Planning Co. Ltd., Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Reva Medical LLC and Terumo Corporation.

Key Questions Answered in This Report

  • 1. What was the size of the global bioabsorbable stents market in 2023?
  • 2. What is the expected growth rate of the global bioabsorbable stents market during 2024-2032?
  • 3. What are the key factors driving the global bioabsorbable stents market?
  • 4. What has been the impact of COVID-19 on the global bioabsorbable stents market?
  • 5. What is the breakup of the global bioabsorbable stents market based on the biomaterial?
  • 6. What is the breakup of the global bioabsorbable stents market based on the absorption rate?
  • 7. What is the breakup of the global bioabsorbable stents market based on the application?
  • 8. What is the breakup of the global bioabsorbable stents market based on the end user?
  • 9. What are the key regions in the global bioabsorbable stents market?
  • 10. Who are the key players/companies in the global bioabsorbable stents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bioabsorbable Stents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Biomaterial

  • 6.1 Polymer-based Bioabsorbable Stents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Metal-based Bioabsorbable Stents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Absorption Rate

  • 7.1 Slow-Absorption Stents
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Fast-Absorption Stents
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Coronary Artery Disease
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Peripheral Artery Disease
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Cardiac Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Arterius Limited
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 B. Braun SE
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Biotronik SE & Co. KG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 SWOT Analysis
    • 15.3.5 Boston Scientific Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Elixir Medical Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Kyoto Medical Planning Co. Ltd.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Lepu Medical Technology (Beijing) Co. Ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Meril Life Sciences Pvt. Ltd.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Reva Medical LLC
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Terumo Corporation
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis